Perceptions of Tetanus-diphteria-acellular pertussis (Tdap) Vaccination among Korean Women of Childbearing Age
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: The number of cases of pertussis reported has increased gradually in the last decade. Pertussis vaccination is the most effective strategy for the prevention of infection. Despite the fact that young infants are at the highest risk for pertussis, the rate of tetanus-diphtheria-acellular pertussis (Tdap) vaccination is presumed to be very low among women of childbearing age in Korea. The purpose of this study was to investigate the perceptions of women of childbearing age regarding Tdap vaccination in Korea. Materials and Methods: Women of childbearing age, who visited the Department of Obstetrics and Gynecology at 3 University hospitals in the Seoul and Gyeonggi-do provinces of Korea, were surveyed. Individual questionnaires were administered from April to May 2012. Demographic data, Tdap vaccination history, general knowledge about pertussis, and information on factors associated with decision on vaccination were collected. Results: Of the 500 reproductive-age women enrolled, only 4 (0.8%) had received the Tdap. The most common reason for nonvaccination was the lack of awareness of pertussis and information about the Tdap. Totally, 171 (34.2%) responded that they would receive a Tdap vaccination in the future. By multivariate analysis, general confidence in the effectiveness of the vaccine (odds ratio [OR]= 1.88, 95% confidence interval [CI] 1.17 to 3.01) was indicated as an important factor for deciding whether to receive the Tdap vaccine (P < 0.01). Conclusions: The coverage of Tdap vaccination of women of childbearing age, including pregnant women, is very low because of the lack of awareness of pertussis and the Tdap. Education of women of childbearing age about pertussis is very important to increase Tdap vaccination rates among these women, particularly during the perinatal period.
Abstract
Background: The number of cases of pertussis reported has increased gradually in the last decade. Pertussis vaccination is the most effective strategy for the prevention of infection. Despite the fact that young infants are at the highest risk for pertussis, the rate of tetanus-diphtheria-acellular pertussis (Tdap) vaccination is presumed to be very low among women of childbearing age in Korea. The purpose of this study was to investigate the perceptions of women of childbearing age regarding Tdap vaccination in Korea. Materials and Methods: Women of childbearing age, who visited the Department of Obstetrics and Gynecology at 3 University hospitals in the Seoul and Gyeonggi-do provinces of Korea, were surveyed. Individual questionnaires were administered from April to May 2012. Demographic data, Tdap vaccination history, general knowledge about pertussis, and information on factors associated with decision on vaccination were collected. Results: Of the 500 reproductive-age women enrolled, only 4 (0.8%) had received the Tdap. The most common reason for nonvaccination was the lack of awareness of pertussis and information about the Tdap. Totally, 171 (34.2%) responded that they would receive a Tdap vaccination in the future. By multivariate analysis, general confidence in the effectiveness of the vaccine (odds ratio [OR]= 1.88, 95% confidence interval [CI] 1.17 to 3.01) was indicated as an important factor for deciding whether to receive the Tdap vaccine (P < 0.01). Conclusions: The coverage of Tdap vaccination of women of childbearing age, including pregnant women, is very low because of the lack of awareness of pertussis and the Tdap. Education of women of childbearing age about pertussis is very important to increase Tdap vaccination rates among these women, particularly during the perinatal period.
참고문헌 (23)
- Centers for Disease Control and Prevention (CDC), "Pertussis-United States, 2001-2003", MMWR Morb MortalWkly Rep, 54, pp.1283~1286 (2005)
- Tsuji Y, "Current trend and importance of prevention onpertussis", Nihon Rinsho, 67, pp.2207~2212 (2009)
- Campbell H, "Accelerating control ofpertussis in England and Wales", Emerg Infect Dis, 18, pp.38~47 (2012)
- Guiso N, "The global pertussis initiative: report from a round tablemeeting to discuss the epidemiology and detection ofpertussis, Paris, France, 11-12 January 2010", Vaccine, 29, pp.1115~1121 (2011)
- Vitek CR, "Increasein deaths from pertussis among young infants in the UnitedStates in the 1990s", Pediatr Infect Dis, 22, pp.628~634 (2003)
- Bechini A, "Acellular pertussis vaccine use in risk groups (adolescents,pregnant women, newborns and health care workers):a review of evidences and recommendations", Vaccine, 30, pp.5179~5190 (2012)
- Centers for Disease Control and Prevention (CDC), "Updatedrecommendations for use of tetanus toxoid, reduceddiphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipatehaving close contact with an infant aged <12months - Advisory Committee on Immunization Practices(ACIP), 2011", MMWR Morb Mortal Week Rep, 60, pp.1424~1426 (2011)
- Cheong HJ, "Vaccination for adult", pp.133~151 (2012), MIP
- Choe YJ, "National pertussissurveillance in South Korea 1955-2011: epidemiologicaland clinical trends", Int J Infect Dis, 16, pp.e850~e854 (2012)
- Fisher BM, "Behaviors and perceptions regarding seasonal and H1N1influenza vaccination during pregnancy", Am J Obstet Gynecol, 204(6 Suppl 1), pp.S107~S111 (2011)
- Goldfarb I, "Uptake of influenzavaccine in pregnant women during the 2009 H1N1 influenzapandemic", Am J Obstet Gynecol, 204(6 Suppl 1), pp.S112~S115 (2011)
- Naleway AL, "Delivering influenzavaccine to pregnant women", Epidemiol Rev, 28, pp.47~53 (2006)
- 김미정, "임신부의 인플루엔자 백신 접종률 및 관련요인", Infection and Chemotherapy, 41(6), pp.349~354 (2009), 대한감염학회
- Shakib JH, "Should the pertussis case definition forpublic health reporting be refined", J Public Health ManagPract, 15, pp.479~484 (2009)
- Centers for Disease Control and Prevention (CDC), "Pertussisepidemic--Washington, 2012", MMWR Morb MortalWkly Rep, 61, pp.517~522 (2012)
- Castagnini LA, "Impact of maternal postpartum tetanus anddiphtheria toxoids and acellular pertussis immunizationon infant pertussis infection", Clin Infect Dis, 54, pp.78~84 (2012)
- Gall SA, "Maternal immunizationwith tetanus-diphtheria-pertussis vaccine: effect on maternaland neonatal serum antibody levels", Am J ObstetGynecol, 204-334, pp.e1~e5 (2011)
- Leuridan E, "Effect of a prepregnancy pertussis boosterdose on maternal antibody titers in young infants", PediatrInfect Dis J, 30, pp.608~610 (2011)
- Mooi FR, "The case for maternal vaccinationagainst pertussis", Lancet Infect Dis, 7, pp.614~624 (2007)
- Knuf M, "Booster vaccination afterneonatal priming with acellular pertussis vaccine", J Pediatr, 56, pp.675~678 (2010)
- Knuf M, "Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisitionof pertussis antibodies in infants", J Pediatr, 152, pp.655~660 (2008)
- Wood N, "Acellularpertussis vaccine at birth and one month induces antibodyresponses by two months of age", Pediatr Infect Dis J, 29, pp.209~215 (2010)
- Cheng PJ, "Factors influencing women'sdecisions regarding pertussis vaccine: A decisionmakingstudy in the Postpartum Pertussis ImmunizationProgram of a teaching hospital in Taiwan", Vaccine, 28, pp.5641~5647 (2010)